TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 56 filers reported holding TRANSMEDICS GROUP INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,861,570 | +153.0% | 180,120 | +288.0% | 0.00% | – |
Q2 2023 | $3,898,604 | -58.5% | 46,423 | -62.6% | 0.00% | -100.0% |
Q1 2023 | $9,392,262 | -46.7% | 124,023 | -56.6% | 0.00% | -75.0% |
Q4 2022 | $17,636,613 | +111.7% | 285,752 | +43.2% | 0.00% | +300.0% |
Q3 2022 | $8,331,000 | +40.7% | 199,587 | +6.0% | 0.00% | 0.0% |
Q2 2022 | $5,923,000 | +946.5% | 188,310 | +796.7% | 0.00% | – |
Q1 2022 | $566,000 | -40.4% | 21,000 | -57.6% | 0.00% | – |
Q4 2021 | $950,000 | -76.9% | 49,516 | -60.1% | 0.00% | -100.0% |
Q3 2021 | $4,108,000 | -14.1% | 124,125 | -13.9% | 0.00% | 0.0% |
Q2 2021 | $4,785,000 | +1.2% | 144,234 | +26.5% | 0.00% | 0.0% |
Q1 2021 | $4,730,000 | +596.6% | 113,994 | +234.3% | 0.00% | – |
Q4 2020 | $679,000 | -21.8% | 34,100 | -45.8% | 0.00% | – |
Q3 2020 | $868,000 | +533.6% | 62,951 | +454.6% | 0.00% | – |
Q1 2020 | $137,000 | -53.1% | 11,351 | -26.1% | 0.00% | – |
Q4 2019 | $292,000 | -74.3% | 15,360 | -67.9% | 0.00% | -100.0% |
Q3 2019 | $1,138,000 | -11.2% | 47,925 | +8.5% | 0.00% | 0.0% |
Q2 2019 | $1,281,000 | – | 44,190 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Must Asset Management Inc. | 94,202 | $5,168,863 | 12.65% |
Eagle Health Investments LP | 414,205 | $22,677,724 | 5.00% |
Ophir Asset Management Pty Ltd | 295,761 | $16,192,915 | 3.82% |
Sandhill Capital Partners LLC | 732,610 | $40,110,409 | 3.75% |
First Light Asset Management, LLC | 618,100 | $33,840,975 | 3.21% |
NEXT CENTURY GROWTH INVESTORS LLC | 477,482 | $26,142,139 | 2.84% |
Bullseye Asset Management LLC | 70,512 | $3,861 | 2.15% |
Kent Lake Capital LLC | 100,000 | $5,475,000 | 2.10% |
Nicholas Investment Partners, LP | 413,714 | $22,650,842 | 1.69% |
AtonRa Partners | 12,287 | $672,713 | 1.41% |